Opus Point Partners Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-17,700
Closed -$1.73M 69
2015
Q1
$1.73M Sell
17,700
-2,302
-12% -$224K 1.45% 25
2014
Q4
$1.86M Buy
+20,002
New +$1.86M 1.84% 24